<p>A) Lesion scores in mice vaccinated with LACK<sub>ins</sub> and PR 8 vector controls (pooled data from 2 independent experiments). B) Parasite burdens in mice vaccinated with LACK<sub>ins</sub> (n = 5), PR 8 vector control (n = 5), *<i>p</i> = 0.02. C) Cytokine production following challenge infection. Spleens and dNL from vaccinated and control mice were assessed by <i>ex vivo</i> ICS IFN-γ (*<i>p</i> = 0.006). Mean, pooled data from 2 independent experiments ± SEM are plotted (n = 6 for wk 2, n = 5 for wk 6, n refers to number of mice). Cells have been gated on CD4<sup>+</sup> CD44<sup>+</sup>.</p
<p>Panel <b>A</b>. Mice immunized with the MVA-CSP/IL15 vaccine were depleted of CD4 T cells (closed...
<p>A) <i>Ex vivo</i> IFN-γ production by LACK<sub>158–173</sub>-specific CD4<sup>+</sup> T cells. Ce...
<p>Groups of mice (<i>n</i> = 10/group) were immunized i.n. with single H5N1 influenza split vaccine...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>A) Prime-boost and challenge strategy. B) Lesion scores in mice primed with PR8-LACK<sub>ins</sub...
<p>A) Passive transfer in mice of purified IgG from vaccinated and control macaques followed by infl...
<p>To determine if CD8+ T cells alone can mediate influenza protection, mice were primed using diffe...
<p><b>A:</b> Mice were infected with 300,000 EID<sub>50</sub> of X-31 (H3N2) influenza and then were...
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>(<b>A</b>) Numbers of airway CD4<sup>+</sup> T cells, (<b>B</b>) CD8<sup>+</sup> T cells, and (<b...
<p>A) C57BL/6 mice were primed with either X31-GP33 i.n. or LCMV Armstrong i.n. These mice, as well ...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p><b>A</b>. Anti-HES pre-challenge IgG1 titres in control and vaccinated C57BL/6 and IL-17RA-defici...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>A) Mice were primed with LCMV Armstrong and then given serum from X31-GP33 immune mice, naïve mic...
<p>Panel <b>A</b>. Mice immunized with the MVA-CSP/IL15 vaccine were depleted of CD4 T cells (closed...
<p>A) <i>Ex vivo</i> IFN-γ production by LACK<sub>158–173</sub>-specific CD4<sup>+</sup> T cells. Ce...
<p>Groups of mice (<i>n</i> = 10/group) were immunized i.n. with single H5N1 influenza split vaccine...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>A) Prime-boost and challenge strategy. B) Lesion scores in mice primed with PR8-LACK<sub>ins</sub...
<p>A) Passive transfer in mice of purified IgG from vaccinated and control macaques followed by infl...
<p>To determine if CD8+ T cells alone can mediate influenza protection, mice were primed using diffe...
<p><b>A:</b> Mice were infected with 300,000 EID<sub>50</sub> of X-31 (H3N2) influenza and then were...
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>(<b>A</b>) Numbers of airway CD4<sup>+</sup> T cells, (<b>B</b>) CD8<sup>+</sup> T cells, and (<b...
<p>A) C57BL/6 mice were primed with either X31-GP33 i.n. or LCMV Armstrong i.n. These mice, as well ...
<p>Mice were passively immunized before (A) or after (B) virus challenge with Aichi (H3) or WSN (H1)...
<p><b>A</b>. Anti-HES pre-challenge IgG1 titres in control and vaccinated C57BL/6 and IL-17RA-defici...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>A) Mice were primed with LCMV Armstrong and then given serum from X31-GP33 immune mice, naïve mic...
<p>Panel <b>A</b>. Mice immunized with the MVA-CSP/IL15 vaccine were depleted of CD4 T cells (closed...
<p>A) <i>Ex vivo</i> IFN-γ production by LACK<sub>158–173</sub>-specific CD4<sup>+</sup> T cells. Ce...
<p>Groups of mice (<i>n</i> = 10/group) were immunized i.n. with single H5N1 influenza split vaccine...